Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Andrew H who wrote (4795)	11/20/1997 4:25:00 PM
From: opalapril	Read Replies (2) \| Respond to of 17367

Jorge, ¨ Es posible que Calle Muralla (heh heh) crea alguna cosa? Por ejemplo, ¨ Xoma tener deseo de vender mas accionces?

To: Andrew H who wrote (4795)	11/20/1997 6:47:00 PM
From: Pseudo Biologist	Read Replies (2) \| Respond to of 17367

Andy, maybe not so great given my trouble-making angle. And what is it with those people posting in (pseudo?) Spanish without translation? How rude! All in jest, of course. PB

To: Andrew H who wrote (4795)	11/22/1997 1:51:00 PM
From: Robert K.	Read Replies (2) \| Respond to of 17367

More. I am still saying I am unsure if girior approach xoma or the other way around. They were developing bpi back in 90. they say the potential of bpi back then (or the shortcoming of e5). Rick harmon is a biased expert in this arena. So It might be good to hear his opinion too. BTW-medically he is much smarter then i. Cant believe the fda story hasnt been discussed yet. DUH. Are you folks all brain dead or am I nuts again. Perhaps both :-) -speed through life saving drugs -drugs for kids.......................................Think on it.